Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 147,510
  • Shares Outstanding, K 278,320
  • Annual Sales, $ 77,190 K
  • Annual Income, $ -87,330 K
  • 36-Month Beta 0.71
  • Price/Sales 1.83
  • Price/Cash Flow 0.00
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings -0.09 on 03/02/17
  • Next Earnings Date 05/09/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.43 +24.37%
on 04/05/17
0.71 -24.68%
on 04/17/17
+0.03 (+6.96%)
since 03/24/17
3-Month
0.42 +27.33%
on 03/09/17
0.71 -24.68%
on 04/17/17
-0.09 (-13.74%)
since 01/24/17
52-Week
0.31 +72.52%
on 06/28/16
1.43 -62.60%
on 04/27/16
-0.55 (-50.48%)
since 04/22/16

Most Recent Stories

More News
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) concerning possible violations...

AMRS : 0.54 (+1.89%)
Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. - AMRS

NEW YORK, NY / ACCESSWIRE / April 21, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Amyris, Inc. (NASDAQ: AMRS) investors who purchased Amyris stock between March 2, 2017 and...

AMRS : 0.54 (+1.89%)
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Amyris, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) investors concerning the Company and its officers'...

AMRS : 0.54 (+1.89%)
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. ("Amyris" or the "Company") (NASDAQ:AMRS) of the June 19, 2017 deadline to seek the role of lead plaintiff...

AMRS : 0.54 (+1.89%)
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS). Investors who purchased or otherwise acquired...

AMRS : 0.54 (+1.89%)
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Amyris, Inc. - AMRS

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Amyris, Inc. securities (NASDAQ:AMRS) from March 2, 2017 through...

AMRS : 0.54 (+1.89%)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Amyris, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Amyris, Inc. (NASDAQ: AMRS) resulting from allegations...

AMRS : 0.54 (+1.89%)
Amyris Agrees to Exclusive China Manufacturing with Blue California Enabling Continued Record Product Revenue Growth into Asian Markets

Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has expanded the scope of its relationship with Phyto Tech Corp (D/B/A "Blue California"). Blue California is based...

AMRS : 0.54 (+1.89%)
Amyris (AMRS) Shows Strength: Stock Adds 17.2% in Session

Amyris, Inc. (AMRS) moved big last session, as its shares jumped over 17% on the day.

AMRS : 0.54 (+1.89%)
AMTX : 1.14 (-3.14%)
Are Options Traders Betting on a Big Move in Amyris (AMRS) Stock?

Investors in Amyris, Inc. (AMRS) need to pay close attention to the stock based on moves in the options market lately.

AMRS : 0.54 (+1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Support & Resistance

2nd Resistance Point 0.57
1st Resistance Point 0.55
Last Price 0.54
1st Support Level 0.50
2nd Support Level 0.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.